In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer
- 1 October 1994
- Vol. 74 (7) , 1904-1911
- https://doi.org/10.1002/1097-0142(19941001)74:7<1904::aid-cncr2820740713>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Human Renal Carcinoma Line Transfected With Interleukin-2 and/or Interferon Gene(s): Implications for Live Cancer VaccinesJNCI Journal of the National Cancer Institute, 1993
- Effects of Transforming Growth Factor-beta on Human Pulmonary Adenocarcinoma Cell Adhesion, Motility, and Invasion In VitroJNCI Journal of the National Cancer Institute, 1992
- Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.Journal of Clinical Oncology, 1992
- Characterization of the invasive and metastatic phenotype in human renal cell carcinomaClinical & Experimental Metastasis, 1991
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Adhesion molecules controlling lymphocyte migrationCell, 1989
- Functional evidence that intercellular adhesion molecule‐1 (icam‐1) is a ligand for lfa‐1d‐ependent adhesion in t cell‐mediated cytotoxicityEuropean Journal of Immunology, 1988
- Malignant melanoma cell lines selected in vitro for increased homotypic adhesion properties have increased experimental metastatic potentialClinical & Experimental Metastasis, 1986